ACC 2020: ACC Renames Award for DCRI’s Pamela Douglas
ACC 2020: New Risk Metric for TAVR Outcomes Reveals Differences in Site Performance
ACC 2020: VOYAGER PAD Results Add Valuable Knowledge to Field of Peripheral Artery Disease
Updated Meta-Analysis Confirms that Patients with Atrial Fibrillation Undergoing PCI Should Avoid Triple Antithrombotic Therapy with Warfarin
‘Science’ Paper Makes Recommendations for NIH to Lead in Data Sharing
Representatives of the DCRI and Duke Forge contributed to a paper that recommended the NIH strengthen its data sharing requirements, beginning by requiring sharing of clinical trial data.
DCRI Faculty Speak About Clinical Research During COVID-19
Duke-Margolis Paper Details Strategies to Treat COVID-19
Former FDA Commissioners Mark McClellan, MD, PhD, director of the Duke-Margolis Center for Health Policy, and Scott Gottlieb, MD, made recommendations for how the FDA should respond to the novel co
Paper Details Design of ADAPTABLE, First Pragmatic Trial to Use PCORnet®
Preventing Alzheimer’s Disease? Taking the First Step Through the TOMMORROW Trial
The study sought to simultaneously test a method for identifying individuals at high risk for Alzheimer’s disease while testing the efficacy of a potential treatment aimed at targets affecting cell
Patient-Reported Health Data in Pragmatic Trials: Helpful, But Not Without Limitations
Experts on data, including three DCRI faculty, recently published a report on using patient-reported health data in pragmatic trials that stemmed from an NIH Collaboratory roundtable.